期刊文献+

siRNA抑制人前列腺癌PC-3细胞株VEGF的表达及细胞增殖 被引量:2

Inhibition of siRNA on VEGF expression in PC-3 cell line and cell proliferation
下载PDF
导出
摘要 目的:研究小干扰RNA(siRNA)对PC-3人前列腺癌细胞血管内皮生长因子(VEGF)基因表达的抑制作用及抑制癌细胞增殖和诱导凋亡的作用。方法:体外合成特异性靶向人VEGF基因的siRNA,并转染到PC-3细胞中;RT-PCR和Western blotting检测siVEGF对VEGF基因和蛋白表达的抑制作用;MTT法检测siVEGF对癌细胞增殖抑制作用,流式细胞术检测siVEGF诱导细胞凋亡的作用。结果:转染siVEGF1和siVEGF2组VEGF mRNA表达水平与空白对照组比较分别下调了60.32%和70.73%;VEGF蛋白表达水平与空白对照组比较明显受到抑制,最高抑制率达72%;转染阴性对照质粒组VEGF基因和蛋白表达水平都无明显改变。转染siVEGF1和siVEGF2的细胞增殖受到抑制,增殖抑制率分别为49.5%和55.3%,细胞的凋亡率分别为33.9%和42.0%。结论:构建的siRNA VEGF能特异有效下调VEGF基因的表达,瞬时转染siRNA VEGF能有效抑制人前列腺癌细胞PC-3增殖并诱导其凋亡。 Objective To study the inhibitory effect of small interfering RNA (siRNA) on VEGF expression in prostate cancer cell line PC-3 and to observe its influences in cell proliferation and apoptosis. Methods Two siRNAs against the VEGF gene were designed and transfected into PC-3 cells respectively, VEGF gene and protein expressions were measured by RT-PCR and Western blotting. Cell proliferation was measured with MTT assay, apoptosis was measured with flow cytometry (FCM). Results The VEGF mRNA expressions were down- regulated by 60.32 % and 70.73%, and the VEGF protein expressions were maximally down-regulated.by 72% after transfecting with siVEGF1 and siVEGF2, respectively. The inhibitory rates of cell proliferation were 49.5% and 55.3 % the apoptotic rates after transfecting were 33.9 % and 42.0%. Conclusion siRNA against VEGF could effectively down-regulate VEGF expression in PC-3 cell line, it can inhibit cell growth and induce apoptosis.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2008年第4期585-589,共5页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅社会发展项目资助课题(200505118)
关键词 SIRNA 血管内皮生长因子 前列腺肿瘤 逆转录聚合酶链反应 流式细胞术 siRNA vascular endothelial growth factor prostate neoplasms flow cytometry reverse transcriptasepolymerase chain reaction
  • 相关文献

参考文献11

  • 1杨俊福,程传宇,武玉东,赵亚兵,梁宏,魏金星.前列腺癌患者癌组织前列腺干细胞抗原、血清前列腺特异抗原检测[J].郑州大学学报(医学版),2007,42(4):717-719. 被引量:3
  • 2祖雄兵,叶章群,周四维,齐琳,申鹏飞.淋巴管密度和功能形态与膀胱癌淋巴结转移关系的研究[J].中华泌尿外科杂志,2006,27(4):224-226. 被引量:3
  • 3Teo NB, Shoker BS, Martin L, et al. A ngiogenesis in preinvasive cancers[J]. Anticancer Res, 2002; 22 (4): 2061-2072.
  • 4韩振国,王岩,李国栋.肝细胞生长因子/扩散因子和血管内皮生长因子对肿瘤血管再生的影响[J].吉林大学学报(医学版),2004,30(3):376-378. 被引量:17
  • 5Kroll J, Waltenberger J. Regulation of the endothelial function and angiogenesis by vascular endothelial growth factor[J].A Z Cardiol, 2000, 89 (3): 206-218.
  • 6Yuan A, Yu CJ, Chen WJ, et al. Correlation of total VEGF mRNA and protein expression with histo logictype, tumor angiogenesis, patient survival and timing of relapse in nonsmall-cell lung cancer [J].Int J Cancer, 2000, 89 (6): 475-483
  • 7MacManus MT, Sharp PA. Gene silencing in mammals by small interference RNAs[J]. Nat Rev Genet, 2002, 3:737-747.
  • 8Mammalian SY. RNAi for the masses[J].Trends Genet, 2003, 19 (1): 9-12.
  • 9Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 212 and 222 nudeotide RNAs[J].Genes Dev,2001, 15: 188-200.
  • 10Hutvagner G, Zamore PD. RNAi: nature abhors a double-strand[J].Curr Op in Genet, 2002, 12: 225-232.

二级参考文献25

  • 1祖雄兵,齐琳,叶章群,周四维,申鹏飞.淋巴管内皮生长因子-C在膀胱移行细胞癌中的表达及其临床意义[J].临床泌尿外科杂志,2004,19(9):551-554. 被引量:9
  • 2[1]Kumar-Sinha C,Chinnaiyan AM.Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer[J].Urology,2003,62(Suppl 1):19
  • 3[2]Tavtigian SV,Simard J,Teng DH,et al.A candidate prostate cancer susceptibility gene at chromosome 17p[J].Nat Genet,2001,27(2):172
  • 4[3]Zhigang Z,Wenlv S.Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues:implications for prostate carcinogenesis and progression of prostate cancer[J].Jpn J Clin Oncol,2004,34(7):414
  • 5[4]Valdman A,Fang X,Pang ST,et al.Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer[J].Prostate,2004,60(4):367
  • 6[5]Luo J,Zha S,Gage WR,et al.Alpha-methylacyl-CoA racemase:a new molecular marker for prostate cancer[J].Cancer Res,2002,62(8):2 220
  • 7[6]Reiter RE,Gu ZN,Watabe T,et al.Prostate stem cell antigen:a cell surface marker overexpressed in prostate cance[J].Proc Natl Acad Sci USA,1998,95(4):1 735
  • 8[7]Saffran DC,Raitano AB,Hubert RS,et al.Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts[J].Proc Natl Acad Sci USA,2001,98(5):2 658
  • 9[8]Stamey TA.Preoperative serum prostate-specific antigen (PSA) below 10microg/l predicts neither the presence of prostate cancer nor the rate of postoperative PSA failure[J].Clin Chem,2001,47(4):631
  • 10Arenberg DA, Kunkel SL, Polverini PJ, et al. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer ( NSCLC )tumorigenesis and spontaneous metastases [J]. J Exp Med,1996, 184: 981-992.

共引文献19

同被引文献23

  • 1沈建军,刘家云,苏明权,缪应业,张青,郝晓柯.用RNAi沉默survivin基因表达对前列腺癌细胞系PC3的影响[J].中国肿瘤生物治疗杂志,2006,13(1):37-41. 被引量:4
  • 2Mody M, Dharker N, Bloomston M, et al. Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202 [J]. Endocr Relat Cancer, 2007, 14(2) :305.
  • 3Kristiansen G, Jacob J, Buckendahl AC, et al. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times [ J ]. Clin Cancer Res, 2006, 12 (21) :6 444.
  • 4Garcia-Bates TM, Bernstein SH, Phipps RP. Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells [ J ]. Clin Cancer Res,2008, 14 ( 20 ) :6 414.
  • 5Naugler WE, Karin M. NF-kappa B and cancer-identifying targets and mechanisms[J]. Curr Opin Genet Dev, 2008, 18(1) :19.
  • 6Schindler R, Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells[J]. J Nutr,2006,136 (6) :1 477.
  • 7Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells [ J ]. Biochem Biophys Res Commun, 1989,161(2) :851.
  • 8Krecicki T, Fraczek M, Kozlak J,et al. Bcl-xL protein expres- sion in laryngeal squamous cell carcinoma [J]. Clin Otolaryn- gol,2004,29(1 ) :55 -58.
  • 9Zhao WL, Daneshpouy ME, Mounier N,et al. Prognostic sig- nificance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma[J]. Blood, 2004,103 (2) : 695-697.
  • 10Watanabe J, Kushihata F, Honda K,et al. Prognostic significance of Bcl-xL in human hepatocellular carcinoma[J]. Surgery, 2004, 135(6) :604-612.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部